BVS
Bioventus Inc.Company with tickers: BVS
CIK
1665988
CUSIP
09075A108
Shares Outstanding
67,748,048
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $123,876,000 | USD | 2025-03-29 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $83,056,000 | USD | 2025-03-29 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $3,011,000 | USD | 2025-03-29 | 10-Q | 2026-05-06 |
| Operating Income | $4,869,000 | USD | 2025-03-29 | 10-Q | 2026-05-06 |
| Net Income | $-2,637,000 | USD | 2025-03-29 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-0.04 | USD/shares | 2025-03-29 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-0.04 | USD/shares | 2025-03-29 | 10-Q | 2026-05-06 |